Journal Logo

Publication Only: Myeloma and other monoclonal gammopathies – Clinical

PB2127 BORTEZOMIB-HIGH DOSE METHYLPREDNISOLONE OFFERS IMPROVED HAEMATOLOGICAL RESPONSES AND OVERALL SURVIVAL COMPARED TO BORTEZOMIB-DEXAMETHASONE IN SYSTEMIC LIGHT CHAIN AMYLOIDOSIS

Mahmood, A. S.1; Sachchithanantham, S.1; Harrison, S.2; Manwani, R.1; Sharpley, F.1; Quarta, C.1; Rezk, T.1; Martinez De Azcona Naharro, A.1; Yong, K.3; Rabin, N.3; Popat, R.3; Kyriacou, C.3; Papanikolaou, X.3; D'Sa, S.3; Lachmann, H.1; Whelan, C.1; Gillmore, J.1; Fontana, M.1; Hawkins, P.1; Wechalekar, A.1

Author Information
doi: 10.1097/01.HS9.0000566992.77698.56
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.